E-AUSHADHI Portal is live now

Most awaited portal E-AUSHADHI, finally made live by the Ministry of AYUSH to increase transparency and accountability for online licensing of Ayurveda, Siddha, Unani and Homoeopathy drugs and related matters.

Shripad Yesso Naik, AYUSH Minister shared that this portal developed with the aim to give transparency, better information management facility and excellent data usability and increased accountability while addressing the gathering at the launch programme. He also made some points clear that there would be fixed timelines for application processing through the portal and user will get a text message and email status updates at each step of the application process. He also said that this kind of projects is an initiative of the Ministry of AYUSH as a reflection of our government’s commitment towards e-governance, ease of doing business and Make in India.

Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH also shared on the occasion of launching that the ministry endeavored to come out with new initiatives and solutions to address the problems faced by practitioners, manufacturers, and consumers of AYUSH medicines.

With the help of this portal, real-time information of the licensed manufactures can be obtained and it would aid the problems of licensing authority, manufactures, and consumers. The government can check the list of verified products, canceled and spurious drugs, contact details of the authority concerned for specific grievances at any time.

Related Posts

‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

Best in Class ‘Made in India’ Surgical Robot is proving Best Bet New Delhi: ‘Made in India’ best in class surgical robot SSiMantra is proving godsend for cancer patients in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise